PDL BioPharma (PDLI) to Offer $150M in Convertible Senior Notes
Tweet Send to a Friend
PDL BioPharma, Inc. (NASDAQ: PDLI) announced today that it intends to offer, subject to market and other conditions, $150 million ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
